Intera Atlas
Run match
Sites / Synexus Clinical Research US
Is this you?

Request access for Synexus Clinical Research US with your @trialmed.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

Synexus Clinical Research US

Unclaimed profile

Site Network · Manchester, England (global); US operations, 929 North Front St. Wilmington, NC 28401 · ~250+ sites

WebsiteLinkedInRank for protocol
Intera lens
ICP 8Lift (cardio sample) 0.15Recruit soph 0.57
Quality Scorecard (1–100)
Overall69Recruit82Ops67Sponsor62Ther61

Performance (observed)

Historical trials
171
Completed
111
Terminated/Withdrawn
21
Completion rate
84%
Active now
39
Phase 2
66
Phase 3
100
Realized enrollment
601,099
First study year
2015
Years active
11
Match confidence
high
Enrollment velocity (inf)
54,645

Therapeutic

Areas
Multi-specialty (early phase and late phase, Phase I-IV)
Specialties
Multiple therapeutic areas
Breadth (conditions)
145
States
Arizona, Florida, Georgia, Nebraska, Texas, and 40+ additional states globally

Recruitment (web observed)

Trial Finder
Yes
Patient database
Y (Access to large patient registry)
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Trial recruitment presence
Capability notes
Very High - 250+ sites, 1.5M+ patient access globally, centralized patient engagement

Relationships

Sponsors
Eli Lilly and Company; Pfizer; Janssen Research & Development, LLC; Merck Sharp & Dohme LLC; Allergan; ModernaTX, Inc.
CROs
PPD Development, LP
Owner / parent
Synexus/Trialmed (formerly acquired Radiant Research and Research Across America; now unified brand)
Acquisitions
Part of Trialmed/PPD Group
Expansion
US operations expansion

Capacity & people

Investigators
—
Coordinators
—
CEO
Christophe Berthoux (previously); Current CEO Unknown post-rebranding to Trialmed
VP Clinical Ops
Jane Restorick (COO at Synexus level)
VP Site Ops
Regional directors (decentralized structure)
VP Recruitment
Janet Jones (VP Access to Patients, former CRO Icon)
Emails
Unknown (Trialmed corporate)

Tech & DCT

Uses AI
Yes
Builds tech
Builds Internally + Vendors
Home visits
Y (site mentions)
DCT / decentralized
Y (US operations, multiple sites)
Tech stack
Data-driven site selection, patient engagement platforms, centralized database (20M patient records)
Recruiting visible
Y

Notes

ClinicalTrials.gov signal: 6 recruiting trials across 6 locations (Arizona, Florida, Georgia, Nebraska, Texas). Major global site network (185+ sites pre-rebranding), 1,500+ employees. Recently rebranded from Synexus to Trialmed. Strong tech-forward approach with data-driven recruitment. Mentions remote/at-home visits (DCT capability). Excellent scale for enrollment but more enterprise-focused.

Recommendation features (sample indication)

Ind fit 0.35Liftability 0.15Overall69

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.